DKSH Investor Relations: Leadership Update

DKSH Strengthens its Healthcare Own Brands Business With the Acquisition of the Meliane® Brand

DKSH has signed an agreement to acquire the Meliane oral contraceptive brand from Bayer across 30 markets in Europe, North Africa, Asia, and the Middle East. The acquisition is in line with DKSH’s strategy to expand its Healthcare Own Brands portfolio and strengthen its presence in higher-value segments and services.

Corrigendum: DKSH Delivers Another Solid Operating Performance, Strong Cash Flow Generation, and Higher EPS in H1 2026

Corrigendum to the ad hoc announcement of 17 July 2026: EPS in H1 2026 was CHF 1.56 (not CHF 1.67), representing growth of 10.6% compared to H1 2025 (not 18.2%). The full text of the corrected announcement is as follows: Net sales of CHF 5.5 billion (+4.9% at CER1) Core EBIT of CHF 163.4 million (+3.6% at CER) Core EBIT margin of 3.0% Increase of Earnings per share (EPS) by 10.6% to CHF 1.56 Free Cash Flow of CHF 147.7 million (130.8% cash conversion rate) Three acquisitions announced in H1 2026 and good pipeline for H2 Stronger H2 expected: improving commercial momentum, data center project pipeline and M&A potential Mid-term roadmap confirmed

DKSH Delivers Another Solid Operating Performance, Strong Cash Flow Generation, and Higher EPS in H1 2026

Net sales of CHF 5.5 billion (+4.9% at CER1) Core EBIT of CHF 163.4 million (+3.6% at CER) Core EBIT margin of 3.0% Increase of Earnings per share (EPS) by 18.2% to CHF 1.67 Free Cash Flow of CHF 147.7 million (130.8% cash conversion rate) Three acquisitions announced in H1 2026 and good pipeline for H2 Stronger H2 expected: improving commercial momentum, data center project pipeline and M&A potential Mid-term roadmap confirmed

DKSH Performance Materials Scales its Personal Care Business by Acquiring Gale & Cosm in Italy

DKSH announced today the closing of an agreement to acquire Gale & Cosm, an Italy-based distributor of specialty chemicals serving the personal care industry. The transaction enhances DKSH Performance Materials’ Life Science business by strengthening its presence in Italy and expanding its formulation and laboratory capabilities for key personal care applications.

DKSH Technology Scales Its Operations in Malaysia by Acquiring the Business of Kinematic Resources

DKSH has closed an agreement to acquire the business of Kinematic Resources Sdn. Bhd. (“Kinematic”), a leading Malaysian distributor of high-value scientific and analytical instruments in Malaysia. With this transaction, DKSH Technology further scales its operations in Malaysia in line with the Business Unit’s strategy to solidify its position as a leading scientific solutions provider in Asia and Beyond.

Minority Shareholders of DKSH Holdings (Malaysia) Berhad Reject Take-Over Offer by DKSH Holding Ltd. at Extraordinary General Meeting

At the Extraordinary General Meeting (“EGM”) that was held today in Kuala Lumpur, Malaysia, the minority shareholders of DKSH Holdings (Malaysia) Berhad (“DHMB”) have rejected the take-over offer that DKSH Holding Ltd. (“DKSH”) submitted through its subsidiaries.

DKSH’s 93rd Annual General Meeting 2026

Shareholders approved all motions with a clear majority Reelection of the current Board members seeking another term as well as the Chairman of the Board of Directors Election of three new Board members, establishing a female majority on the Board of Directors Proposal of dividend increase of 6.4% to CHF 2.50 per share accepted

DKSH Performance Materials Acquires AIC Ingredients, a Leading Customized Food Solutions Manufacturer in Malaysia

DKSH announced today the signing of an agreement to acquire AIC Ingredients, a Malaysia-based manufacturer of functional food ingredients with a leading position in the Malaysian bakery sector. This strategic move significantly strengthens the position of DKSH Performance Materials in the highly attractive and growing market of tailored functional ingredients across Southeast Asia.